St. Olavs Hospital HF — Sponsor Intelligence | 16 EU Trials

Filter these 16 trials by condition, phase, country and more.

Open in Search →

16 Registered trials

6 Recruiting

4 Completed trials

4 Countries active

19 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 4 Phase II: 9 Phase IV: 3

Oversight events:

2 temporary halts across 2 trials

View oversight register →

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Testicular seminoma (pure) stage I 1

Top IMPs

SODIUM CHLORIDE 3 ATORVASTATIN 2 BOTULINUM TOXIN TYPE A 1 CABERGOLINE 1 INSULIN LISPRO 1 IRINOTECAN HYDROCHLORIDE TRIHYDRATE 1 OXALIPLATIN 1 OXYTOCIN 1 ROPEGINTERFERON ALFA-2B 1 TRANEXAMIC ACID 1

All trials

16 total

Atorvastatin in episodic migraine Not authorised

2022-502176-23-00 Phase II 1 country ATORVASTATIN
Atorvastatin in chronic migraine (StainMigChronic) Not authorised

2022-502177-42-01 Phase II 1 country ATORVASTATIN
Oxytocin & benzodiazepines Pending

2024-516262-11-00 Phase II 1 country OXYTOCIN; SODIUM CHLORIDE
Episodic CandClus2: A randomized, placebo-controlled, triple blind study of candesartan in adults with episodic cluster headache Pending

2025-521470-34-00 Phase III 2 countries
Chronic CandClus2: A randomized, placebo-controlled, triple blind crossover study of candesartan in adults with chronic cluster headache Pending

2025-521529-34-00 Phase III 2 countries
A randomized study in testicular cancer without metastasis, comparing two different types of chemotherapy used to reduce the risk of relapse Recruiting

2024-518399-29-00 Phase III 2 countries
COSENSE-1: A feasibility study for using a functional precision medicine platform to select oxaliplatin-based versus irinotecan-based chemot… Recruiting

2024-517677-25-00 Phase II 1 country IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN
The Effect of Topical Tranexamic Acid on Postoperative Complications in Soft Tissue Plastic Surgery. A Multicenter Randomized Controlled Tri… Recruiting

2023-510381-28-01 Phase IV 3 countries SODIUM CHLORIDE; TRANEXAMIC ACID
Atorvastatin in episodic migraine Recruiting

2022-502176-23-01 Phase II 1 country
Atorvastatin in chronic migraine (StainMigChronic) Recruiting

2022-502177-42-02 Phase II 1 country
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study Recruiting

2024-515350-25-01 Phase IV 3 countries
A STUDY OF EFFICACY AND SAFETY OF LONG-ACTING LOW DOSE ROPEGINTERFERON IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH BOSUTINIB FROM… Ended

2024-517417-32-00 Phase II 4 countries ROPEGINTERFERON ALFA-2B
Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) – a randomized controlled trial Ended

2023-510039-12-00 Phase IV 1 country CABERGOLINE
Premixed glucagon/insulin solution for faster insulin absorption in Type 1 diabetes. Halted

2023-510408-32-02 Phase II 1 country INSULIN LISPRO
Glucagon enhanced insulin absorption in Diabetes Mellitus type 1 Ended

2022-502455-57-01 Phase II 1 country
The MiBlock study Ended

2024-515165-34-00 Phase III 1 country BOTULINUM TOXIN TYPE A; SODIUM CHLORIDE

Showing 1–16 of 16 trials

← All sponsors A–Z